Investegate |Scancell Hlds Announcements | Scancell Hlds: Modi-1 Phase I/II CTA approved by MHRA
Investegate announcements from Scancell Hlds, Modi-1 Phase I/II CTA approved by MHRA
Source: investegate.co.uk
Page 7 - John Chiplin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Chiplin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Chiplin Today - Breaking & Trending Today
Investegate |Scancell Hlds Announcements | Scancell Hlds: Director Dealing
ImmunoBody ® vaccines target dendritic cells and stimulate both CD4 and CD8 T cells with the ability to identify, target and eliminate cancer cells. These cancer vaccines have the potential to be used as monotherapy or in combination with checkpoint inhibitors and other agents. The Directors believe that this platform has the potential to enhance tumour destruction, prevent disease recurrence and extend survival. · SCIB1, Scancell's lead product, is being developed for the treatment of metastatic melanoma. In a Phase 1/2 clinical trial, survival with SCI...
Source: investegate.co.uk